SeaCrest Wealth Management’s Cue Biopharma CUE Stock Holding History

SeaCrest Wealth Management’s Portfolio CUE Stock Details CUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-333	Closed	-$2.3K	–	570
2026 Q1	$2.3K	Hold	333	–	–	﹤0.01%	634
2025 Q4	$3.87K	Hold	333	–	–	﹤0.01%	632
2025 Q3	$8.58K	Sell	333 -100	-23%	-$2.35K	﹤0.01%	627
2025 Q2	$8.87K	Hold	433	–	–	﹤0.01%	617
2025 Q1	$11.8K	Hold	433	–	–	﹤0.01%	655
2024 Q4	$14.2K	Hold	433	–	–	﹤0.01%	653
2024 Q3	$9.84K	Hold	433	–	–	﹤0.01%	649
2024 Q2	$16.1K	Hold	433	–	–	﹤0.01%	612
2024 Q1	$24.6K	Sell	433 -34	-7%	-$2.4K	﹤0.01%	600
2023 Q4	$36.7K	Hold	467	–	–	﹤0.01%	615
2023 Q3	$32.2K	Hold	467	–	–	﹤0.01%	616
2023 Q2	$51.1K	Hold	467	–	–	0.01%	619
2023 Q1	$50K	Hold	467	–	–	0.01%	617
2022 Q4	$39.9K	Sell	467 -66	-12%	-$6.04K	0.01%	622
2022 Q3	$36K	Hold	533	–	–	0.01%	615
2022 Q2	$40K	Hold	533	–	–	0.01%	1213
2022 Q1	$78K	Hold	533	–	–	0.01%	700
2021 Q4	$181K	Sell	533 -134	-20%	-$51.8K	0.02%	664
2021 Q3	$291K	Hold	667	–	–	0.04%	498
2021 Q2	$233K	Hold	667	–	–	0.03%	586
2021 Q1	$244K	Hold	667	–	–	0.03%	531
2020 Q4	$250K	Buy	+667	New	+$267K	0.04%	490

Other funds holding CUE

RSWM

Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return

AWM

Angeles Wealth Management Santa Monica, California $2.19B AUM 23.13% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Gleason Group Prospect, Kentucky $1.15B AUM 21.11% 1-Year Est. Return

GSWM

Golden State Wealth Management Santa Ana, California $1.1B AUM 27.49% 1-Year Est. Return

PWA

Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SeaCrest Wealth Management's CUE Position: Q2 2026 in Review

SeaCrest Wealth Management sold out of Cue Biopharma (CUE) in Q2 2026, closing a stake of 333 shares — an estimated $2.3K sold.

SeaCrest Wealth Management first reported a position in CUE in Q4 2020 and held it in 22 quarters. The position peaked at $291K in Q3 2021. 8 funds tracked by Wall St. Rank hold CUE as of Q2 2026.

SeaCrest Wealth Management reported no remaining Cue Biopharma position as of Q2 2026 after selling out during the quarter.
SeaCrest Wealth Management sold 333 Cue Biopharma shares in Q2 2026, an estimated $2.3K.
SeaCrest Wealth Management first reported a position in Cue Biopharma in Q4 2020 and held it in 22 quarters.
SeaCrest Wealth Management's Cue Biopharma position peaked at $291K in Q3 2021.
8 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2026.

Based on SeaCrest Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.